Top compounds associated with response to ERMARD


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.012 0.8
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.01 0.8
mRNA ML312 CTRPv2 pan-cancer AAC -0.024 0.8
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0093 0.8
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.011 0.8
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.022 0.8
mRNA PF-562271 GDSC1000 pan-cancer AAC -0.0098 0.8
Download CSV